Stockscreener 앱 받기
156.44
3.43%
5.19
시간 외 거래:
156.44
전일 마감가:
$151.25
열려 있는:
$154.5
하루 거래량:
376.68K
Relative Volume:
0.76
시가총액:
$4.68B
수익:
$802.80M
순이익/손실:
$53.51M
주가수익비율:
90.43
EPS:
1.73
순현금흐름:
$91.12M
1주 성능:
-1.45%
1개월 성능:
+6.03%
6개월 성능:
-17.99%
1년 성능:
-6.79%
1일 변동 폭
$153.09
$158.75
1주일 범위
$133.32
$163.35
52주 변동 폭
$123.00
$225.00
Inspire Medical Systems Inc Stock (INSP) Company Profile
명칭
Inspire Medical Systems Inc
전화
763-957-5037
주소
5500 WAYZATA BLVD, GOLDEN VALLEY
INSP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
156.44 | 4.68B | 802.80M | 53.51M | 91.12M | 1.73 |
|
ABT
Abbott Laboratories
|
131.99 | 230.70B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.87 | 154.22B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
388.08 | 145.74B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.81 | 107.03B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.80 | 44.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-20 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-05-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-04-19 | 개시 | RBC Capital Mkts | Outperform |
| 2024-03-19 | 개시 | Morgan Stanley | Overweight |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | 개시 | Jefferies | Buy |
| 2024-01-02 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-04-14 | 개시 | Mizuho | Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-12-13 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | 개시 | Truist | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Peer Perform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-12-15 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-11-03 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-11-03 | 업그레이드 | Oppenheimer | Underperform → Perform |
| 2020-09-22 | 개시 | JP Morgan | Overweight |
| 2020-09-02 | 개시 | Robert W. Baird | Outperform |
| 2020-08-06 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-07-15 | 개시 | Goldman | Buy |
| 2020-06-18 | 재확인 | Piper Sandler | Overweight |
| 2020-05-18 | 개시 | Lake Street | Buy |
| 2020-04-28 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | 개시 | Piper Sandler | Overweight |
| 2020-01-28 | 개시 | Oppenheimer | Underperform |
| 2020-01-27 | 개시 | Oppenheimer | Underperform |
| 2019-11-06 | 업그레이드 | Berenberg | Sell → Hold |
| 2019-02-05 | 개시 | Dougherty & Company | Buy |
| 2018-11-28 | 개시 | Berenberg | Sell |
| 2018-10-29 | 개시 | Leerink Partners | Outperform |
| 2018-05-29 | 개시 | Guggenheim | Buy |
| 2018-05-29 | 개시 | Stifel | Buy |
| 2018-05-29 | 개시 | Wells Fargo | Outperform |
모두보기
Inspire Medical Systems Inc 주식(INSP)의 최신 뉴스
3 Healthcare Stocks to Keep an Eye On - Yahoo Finance
Inspire Medical Systems, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 20, 2024 to Discuss Your RightsINSP - ACCESS Newswire
Lost Money on Inspire Medical Systems, Inc.(INSP)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Inspire Medical Systems, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More InformationINSP - ACCESS Newswire
Investors Who Lost Money on Inspire Medical Systems, Inc. (INSP) Should Contact Levi & Korsinsky About Pending Class Action – INSP - ACCESS Newswire
Inspire medical systems outlines full launch of Inspire V with 17%-19% 2025 revenue growth target - MSN
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio - Yahoo Finance
Inspire Medical Systems, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates - Yahoo Finance
INSP Stock Gains Following Q1 Earnings Beat, Gross Margin Contracts - MSN
All You Need to Know About Inspire (INSP) Rating Upgrade to Buy - Yahoo Finance
Inspire Medical Systems (INSP) Target Price Lowered by Morgan St - GuruFocus
Wall Street Analysts Predict a 39.04% Upside in Inspire (INSP): Here's What You Should Know - Yahoo Finance
Inspire Medical Systems, Inc. (NYSE:INSP) Q1 2025 Earnings Call Transcript - Insider Monkey
Breaking Down Inspire Medical Systems: 13 Analysts Share Their Views - Benzinga
INSP's Q1 Revenue Surpasses Expectations with Strong Growth | IN - GuruFocus
Inspire Medical to fully launch next-gen system in U.S. this month - MassDevice
JP Morgan Maintains Overweight Rating, Lowers PT for Inspire Med - GuruFocus
Inspire Medical Systems (INSP) Target Price Lowered by Morgan Stanley | INSP Stock News - GuruFocus
JP Morgan Maintains Overweight Rating, Lowers PT for Inspire Medical Systems (INSP) | INSP Stock News - GuruFocus
Inspire Medical Systems (INSP) Price Target Lowered by Wells Fargo | INSP Stock News - GuruFocus
Inspire Medical (INSP) Faces Price Target Reduction Amid Mid-Yea - GuruFocus
Inspire Medical (INSP): Morgan Stanley Updates Price Target Amid - GuruFocus
Inspire Medical (INSP): Morgan Stanley Updates Price Target Amidst Positive Outlook | INSP Stock News - GuruFocus
Inspire Medical Systems (INSP) Target Price Raised by Baird | IN - GuruFocus
Inspire Medical (INSP) Price Target Increased by Baird | INSP St - GuruFocus
Inspire Medical (INSP) Price Target Increased by Baird | INSP Stock News - GuruFocus
Morgan Stanley Cuts Price Target on Inspire Medical Systems to $200 From $220, Keeps Overweight Rating - marketscreener.com
Inspire Medical Systems’ revenue up 23% to USD 201.3M in Q1 2025 - Medical Buyer
Inspire Medical Systems Inc (INSP) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Decoding Inspire Medical Systems Inc (INSP): A Strategic SWOT In - GuruFocus
Inspire Medical Systems Reports Strong Q1 2025 Growth - TipRanks
Inspire: Q1 Earnings Snapshot - MySA
Inspire Medical Systems Q1 2025 Earnings Call Transcript - MarketBeat
Inspire Medical Systems earnings beat by $0.34, revenue topped estimates - Investing.com Canada
Earnings call transcript: Inspire Medical Systems beats Q1 2025 EPS expectations - Investing.com Nigeria
Inspire Medical Systems (INSP) Reports Strong Q1 Growth and Key Developments - GuruFocus
Inspire medical systems director Shawn McCormick sells $57,600 in stock By Investing.com - Investing.com India
Inspire medical systems director Shawn McCormick sells $57,600 in stock - Investing.com
Inspire Medical Systems Q1 2025 slides: Revenue up 23% as Inspire V launch approaches By Investing.com - Investing.com South Africa
Inspire (INSP) Updates Revenue and Earnings Guidance for FY25 | INSP Stock News - GuruFocus
Inspire Medical Systems Inc (INSP) Q1 2025 Earnings: EPS of $0.1 - GuruFocus
Inspire Medical Systems beats Q1 estimates, raises EPS outlook - Investing.com Australia
Inspire Medical Systems beats Q1 estimates, raises EPS outlook By Investing.com - Investing.com India
Inspire Medical Systems Q1 2025 slides: Revenue up 23% as Inspire V launch approaches - Investing.com
Inspire Medical Systems (INSP) Surpasses Q1 Earnings and Revenue Estimates - Yahoo
Inspire Medical Systems Swings to Q1 Profit, Revenue Increases; Shares Rise After Hours - marketscreener.com
Inspire Medical Systems Reports Strong Q1 2025 Revenue Growth - TipRanks
Inspire Medical Systems Swings To Profit In Q1 - Nasdaq
Inspire Medical Systems, Inc. SEC 10-Q Report - TradingView
Inspire Medical Systems Reports Strong Q1 2025 Financial ResultsNews and Statistics - IndexBox
Inspire Medical Systems, Inc. Announces First Quarter 2025 Financial Results and Updates 2025 Outlook - The Manila Times
Inspire Medical Systems Inc (INSP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.93%
자본화:
|
볼륨(24시간):